US2544272A - Penicillin salt suspensions - Google Patents

Penicillin salt suspensions Download PDF

Info

Publication number
US2544272A
US2544272A US1277A US127748A US2544272A US 2544272 A US2544272 A US 2544272A US 1277 A US1277 A US 1277A US 127748 A US127748 A US 127748A US 2544272 A US2544272 A US 2544272A
Authority
US
United States
Prior art keywords
penicillin
oil
salt
percent
insoluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US1277A
Inventor
Henry C Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to US1277A priority Critical patent/US2544272A/en
Application granted granted Critical
Publication of US2544272A publication Critical patent/US2544272A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Definitions

  • This invention relates to penicillin salts and more particularly to improvements in oil suspensions of insoluble salts of penicillin.
  • the water-insoluble organic salts of penicillin which are capable of this unexpected prolongation are administered as suspensions in aqueous or oleaginous vehicles.
  • aqueous suspensions When aqueous suspensions are used, the suspension must be freshly prepared because of the well known instability of penicillin in the presence of moisture.
  • no substantial amount of moisture is present in the preparation and in such mixtures the penicillin salts are stable over a long period of time. According y. it is most convenient to supply oil suspensions to the trade, and to furnish the preparations in bottles containing the insoluble penicillin salt in finely divided form already mixed with the oil vehicle.
  • the insoluble salt of penicillin which of course is finely divided to permit its free passage through the lumen of the hypodermic needle, does not remain in suspension, however, and before parenteral administration it is necessary for the technician or physician to resuspend the salt by agitating the preparation, as by shaking. It has been found that after standing for a period of a few days the finely divided salt which separates from the oil vehicle forms a stable mass of solid material which is resuspendable only by prolonged and violent agitation of the bottle containing the penicillin-oil mixture. The reason for the formation of this stable layer of solid material is not understood.
  • Mixtures of insoluble organic penicillin salts and oleaginous vehicles prepared in accordance with this invention may be mixed by mere gentle shaking, to produce uniform and complete suspensions of the insoluble penicillin salts in the vehicles, even after the mixtures have stood for long periods of time.
  • compositions In the provision of novel compositions according to my invention, care must be exercised in the selection of the emulsifying agents used to prevent the formation of the undesirable stable layer of insoluble penicillin salt, and especially so since the compositions are to be administered parenterally as medicaments.
  • the agents chosen must be nontoxic, must be oil-soluble, must be substantially free from irritating properties, must not impart undesirable odor or color to the medicament and must have no untoward action upon the oil vehicle or the insoluble penicillin salt.
  • compositions comprising a group consisting of the fatty acid partial esters of hexitol anhydrides, including such anhydrides as sorbitans, sorbides, mannitans and mannides, and the polyalkylene derivatives of the above anhydrides.
  • Preferred compounds of the above described types of agents are those which contain fatty acid residues having from about 12 to about 18 carbon atoms, for example the residues of oleic, lauric and stearic acids.
  • the preferred polyalkylene derivatives mentioned above are those prepared by reacting ethylene oxide or propylene oxide with the partial fatty acid esters of hexitol anhydrides, with the amount of ethylene oxide or propylene oxide introduced in the molecule not exceeding a ratio of about 25 molecules of oxide to one of the anhydride.
  • the amounts of the above emulsifying agents employed in compositions prepared in accordance with my invention are much less than the range of 2 to 5 percent commonly employed in preparing oil-water emulsions.
  • concentrations of 2 or more percent by volume are effective, efiicient results are obtained when the concentration of emulsifying agent employed in the penicillin salt-oil mixture does not exceed one percent, and surprisingly the effectiveness of the emulsifying agent in producing an easily redispersible penicillin salt mixture attains its optimal value when the concentration is about 0.125 percent. It is difficult to account for this surprising optimal concentration and I I know of no suitable explanation of this phenomenon.
  • compositions prepared in accordance with my invention contain emulsifying agents in effective amounts up to about 1 percent, and most desirably they contain a concentration of about 0.125 percent by volume.
  • procaine penicillin oil suspension prepared in accordance with the above procedure and a sample of procaine penicillin in sesame oil which contained no emulsifying agent were centrifuged at 2500 R. P. M. for about 40 minutes to cause complete separation of the suspended procaine penicillin salt.
  • the procaine penicillin salt in the mixture of oil and emulsifying agent was readily resuspendable upon gentle shaking for a few seconds, whereas the procaine penicillin salt in the plain oil vehicle was resuspendable only upon violent and prolonged'shaklng for manyminutes.
  • Example 2 The procedure of Example 1 may be followed in preparing a composition comprising the following ingredients and proportions thereof:
  • the above composition has a total volume of about 1500 ml. and contains about 0.25 percent of emulsifying agent.
  • Example 3 The following composition containing about 1 percent of emulsifying agent may be prepared according to the procedure of Example 1:
  • Example 4 The following composition containing about 0.08 percent of emulsifying agent may be prepared according to the procedure of Example 1:
  • oleaginous media comprising oils and liquid oil-wax mixtures which may be referred to as physiologically compatible oils, and with which my invention is operative, include both parenterally and topically useful oils.
  • Oils suitable for parenteral administration include the non-drying vegetable oils, such as rapeseed, cottonseed, poppy seed oil and the like, as well as the lower aliphatic esters of the fatty acids, for example ethyl oleate and ethyl stearate.
  • An illustrative example of an oil suitable for topical application is liquid petrolatum.
  • physiologicallycompatible waxes are beeswax and spermaceti.
  • compositions containing the insoluble penicillin salt in finely divided form are desirable. This fine division is especially desirable in compositions intended for injection purposes to avoid the tendency of the particles of the penicillin salt mechanically to pack" in the lumen of the hypodermic needle.
  • penicillin salt-oil suspensions in which the penicillin has been ground or powdered until it will pass through a ZOO-mesh screen.
  • the size of the penicillin salt particles is not critical for the purposes of my invention, and my invention is operative with penicillin salt particles even of such size as will pass through a 40-mesh or coarser screen.
  • a readily redispersible substantially waterfree therapeutic composition comprising a major proportion of an oleaginous vehicle, a minor proportion of a finely divided water-insoluble, and
  • oil-insoluble organic penicillin salt and an amount eifective to cause redispersion and less than about one percent by volume of at least one emulsifying agent of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivativesI 2.
  • An injectable readily redispersible therapeutic composition being substantially water-free, comprising a non-drying vegetable oil, a finely divided water-insoluble, and oil-insoluble organic penicillin saltand in total amount about 0.125 percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyakylene oxide derivatives.
  • a readily redispersible substantially waterfree therapeutic composition comprising a nondrying vegetable oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides "and their polyalkylene oxide derivatives.
  • a readily redispersible substantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of thegroup consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivatives.
  • a readily redispersiblesubstantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause 'redispersion and less than about one percent by volume of a mixture of sorbitan mono-'oleate and the polyethylene oxide derivative of sorbitan mono-oleate.
  • composition according to claim 5 in which the mixture of sorbitan mono-oleate and the poly-' ethylene oxide derivative of sorbitan mono-oleate is present in a concentration of about one eighth of one percent by volume.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Patented Mar. 6, 1951 PENICIILIN SALT SUSPENSIONS Henry C. Miller, Indianapolis, Ind., assignor to Eli Lilly and Company, Indianapolis, Ind., a corporation oflndiana No Drawing. Application January 8, 1948, Serial No. 1,277
6 Claims. (Cl. 167- 58) I This invention relates to penicillin salts and more particularly to improvements in oil suspensions of insoluble salts of penicillin.
It has recently been discovered that certain" organic salts of penicillin having a substantial insolubility in water and oil are valuable in the treatment of infections for which penicillin itself is commonly used. and that these insoluble organic salts possess an advantage over aqueous solutions of the water-soluble metal salts of penicillin in that the duration of action of the penicillin is greatly enhanced. Thus, for example, only one or two parenteral administrations of the insoluble organic penicillin salts are required per diem in place of the six or more injections required when solutions of water-soluble penicillin salts are being administered.
The water-insoluble organic salts of penicillin which are capable of this unexpected prolongation are administered as suspensions in aqueous or oleaginous vehicles. When aqueous suspensions are used, the suspension must be freshly prepared because of the well known instability of penicillin in the presence of moisture. However, in the case of oil suspensions, the subject with which my invention is concerned, no substantial amount of moisture is present in the preparation and in such mixtures the penicillin salts are stable over a long period of time. According y. it is most convenient to supply oil suspensions to the trade, and to furnish the preparations in bottles containing the insoluble penicillin salt in finely divided form already mixed with the oil vehicle. The insoluble salt of penicillin, which of course is finely divided to permit its free passage through the lumen of the hypodermic needle, does not remain in suspension, however, and before parenteral administration it is necessary for the technician or physician to resuspend the salt by agitating the preparation, as by shaking. It has been found that after standing for a period of a few days the finely divided salt which separates from the oil vehicle forms a stable mass of solid material which is resuspendable only by prolonged and violent agitation of the bottle containing the penicillin-oil mixture. The reason for the formation of this stable layer of solid material is not understood.
but whatever its cause, it makes diflicult the reform suspensions of the salts. Other objects will become apparent from the following description.
In the accomplishment of the above and other objects I have discovered that readily resuspendable mixtures of finely divided insoluble organic salts of penicillin in oleaginous vehicles are obtained when there is added to the oleaginous mixture a small amount of one or more agents commonly classified as emulsifying agents. The small amount of emulsifying agent which is added is not sufllcient to produce a stable suspension or even to cause any observable inhibition of the separation of the penicillin salt from the oil vehicle, but surprisingly, for some reason unknown to me, the small amount of agent does prevent the separated salt from forming the solid mass of salt which resists resuspension. Mixtures of insoluble organic penicillin salts and oleaginous vehicles prepared in accordance with this invention, unlike those which have hitherto been used, may be mixed by mere gentle shaking, to produce uniform and complete suspensions of the insoluble penicillin salts in the vehicles, even after the mixtures have stood for long periods of time.
In the provision of novel compositions according to my invention, care must be exercised in the selection of the emulsifying agents used to prevent the formation of the undesirable stable layer of insoluble penicillin salt, and especially so since the compositions are to be administered parenterally as medicaments. The agents chosen must be nontoxic, must be oil-soluble, must be substantially free from irritating properties, must not impart undesirable odor or color to the medicament and must have no untoward action upon the oil vehicle or the insoluble penicillin salt. I have found that emulsifying agents fully meeting the above medical and other requirements are compositions comprising a group consisting of the fatty acid partial esters of hexitol anhydrides, including such anhydrides as sorbitans, sorbides, mannitans and mannides, and the polyalkylene derivatives of the above anhydrides. Preferred compounds of the above described types of agents are those which contain fatty acid residues having from about 12 to about 18 carbon atoms, for example the residues of oleic, lauric and stearic acids. The preferred polyalkylene derivatives mentioned above are those prepared by reacting ethylene oxide or propylene oxide with the partial fatty acid esters of hexitol anhydrides, with the amount of ethylene oxide or propylene oxide introduced in the molecule not exceeding a ratio of about 25 molecules of oxide to one of the anhydride.
The amounts of the above emulsifying agents employed in compositions prepared in accordance with my invention are much less than the range of 2 to 5 percent commonly employed in preparing oil-water emulsions. In my invention, although concentrations of 2 or more percent by volume are effective, efiicient results are obtained when the concentration of emulsifying agent employed in the penicillin salt-oil mixture does not exceed one percent, and surprisingly the effectiveness of the emulsifying agent in producing an easily redispersible penicillin salt mixture attains its optimal value when the concentration is about 0.125 percent. It is difficult to account for this surprising optimal concentration and I I know of no suitable explanation of this phenomenon. I have found that a mixture of emulsifying agents of the above types may be employed and that the most effective results are obtained when the total concentration of the mixure of emulsifying agents is about 0.125 percent. Thus, preferred compositions prepared in accordance with my invention contain emulsifying agents in effective amounts up to about 1 percent, and most desirably they contain a concentration of about 0.125 percent by volume.
Illustrations of novel compositions and their preparation in accordance with my invention are set forth in the following specific examples.
Example .1
24 liters of sesame oil, 24 cc. of the polyethylene oxide derivative of sorbitan mono-oleate and 13.5 cc. of sorbitan mono-oleate are mixed with stirring and the mixture is sterilized by heating it to about 150 C. for 3 hours. The mixture is cooled to about 45 C., and under sterile conditions and with vigorous stirring 9 kg. (9 billion units) of the procaine salt of penicillin in finely divided condition (200 mesh screen) are added. The above composition has a total volume of about 30 liters and on a percentage basis contains about 0.125 percent of emulsifying agent. The sterile suspension thus obtained is then placed in small sterile bottles suitable for distribution to the trade, and sealed. During the filling of the bottles with the sterile suspension of procaine penicillin in oil, it is of course necessary to maintain an even distribution of the penicillin salt in the oil by agitation of the mixture.
A sample of the oil suspension of procaine penicillin prepared in accordance with the above procedure was allowed to stand for two weeks. At the end of the two weeks period the mixture was found to be readily resuspendable by gentle shaking for a few seconds. In comparison, a sample of procaine penicillin suspended in sesame oil without the addition of the emulsifying agent, and which was allowed to stand for two weeks, was found to be resuspendable only upon violent shaking of the sample for a period of about minutes.
A sample of procaine penicillin oil suspension prepared in accordance with the above procedure and a sample of procaine penicillin in sesame oil which contained no emulsifying agent were centrifuged at 2500 R. P. M. for about 40 minutes to cause complete separation of the suspended procaine penicillin salt. The procaine penicillin salt in the mixture of oil and emulsifying agent was readily resuspendable upon gentle shaking for a few seconds, whereas the procaine penicillin salt in the plain oil vehicle was resuspendable only upon violent and prolonged'shaklng for manyminutes.
Example 2 The procedure of Example 1 may be followed in preparing a composition comprising the following ingredients and proportions thereof:
Cottonseed oil ml 1200 Procaine penicillin g 450 sorbitan mono-oleate ml 3.7
The above composition has a total volume of about 1500 ml. and contains about 0.25 percent of emulsifying agent.
Example 3 The following composition containing about 1 percent of emulsifying agent may be prepared according to the procedure of Example 1:
Peanut oil ml 1000 Profiavin penicillin g 250 Polyoxyalkylene derivative of sorbitan monopalmitate ml 9.2.5
Example 4 The following composition containing about 0.08 percent of emulsifying agent may be prepared according to the procedure of Example 1:
Sesame oil ml 2400 Procaine penicillin g 500 Gentian violet salt of penicillin g 400 Sorbitan mono-oleate ml 2.4
dients may be employed.
As is known to the art, a wide variety of oleaginous media may be employed in the preparation of penicillin salt suspensions suitable for therapeutic purposes. Suitable oleaginous dispersion media comprising oils and liquid oil-wax mixtures which may be referred to as physiologically compatible oils, and with which my invention is operative, include both parenterally and topically useful oils. Oils suitable for parenteral administration include the non-drying vegetable oils, such as rapeseed, cottonseed, poppy seed oil and the like, as well as the lower aliphatic esters of the fatty acids, for example ethyl oleate and ethyl stearate. An illustrative example of an oil suitable for topical application is liquid petrolatum. Examples of physiologicallycompatible waxes are beeswax and spermaceti.
As is known, for therapeutic purposes, compositions containing the insoluble penicillin salt in finely divided form are desirable. This fine division is especially desirable in compositions intended for injection purposes to avoid the tendency of the particles of the penicillin salt mechanically to pack" in the lumen of the hypodermic needle. Thus it is the practice to provide penicillin salt-oil suspensions in which the penicillin has been ground or powdered until it will pass through a ZOO-mesh screen. However, the size of the penicillin salt particles is not critical for the purposes of my invention, and my invention is operative with penicillin salt particles even of such size as will pass through a 40-mesh or coarser screen. In general, it may be said that the more finely divided the penicillin salt, the more tenaciously the particles of salt adhere to each other and the more difiicultly the solid mass which settles out is redispersible. Hence, my invention is of greater importance in connection with penicillin salt-oil suspensions in which the penicillin salt is in a finely divided state, a condition which is presently preferred for therapeutic compositions.
I claim:
1. A readily redispersible substantially waterfree therapeutic composition comprising a major proportion of an oleaginous vehicle, a minor proportion of a finely divided water-insoluble, and
oil-insoluble organic penicillin salt and an amount eifective to cause redispersion and less than about one percent by volume of at least one emulsifying agent of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivativesI 2. An injectable readily redispersible therapeutic composition being substantially water-free, comprising a non-drying vegetable oil, a finely divided water-insoluble, and oil-insoluble organic penicillin saltand in total amount about 0.125 percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyakylene oxide derivatives.
3. A readily redispersible substantially waterfree therapeutic composition comprising a nondrying vegetable oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides "and their polyalkylene oxide derivatives.
4. A readily redispersible substantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of thegroup consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivatives.
5. A readily redispersiblesubstantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause 'redispersion and less than about one percent by volume of a mixture of sorbitan mono-'oleate and the polyethylene oxide derivative of sorbitan mono-oleate.
6. A composition according to claim 5 in which the mixture of sorbitan mono-oleate and the poly-' ethylene oxide derivative of sorbitan mono-oleate is present in a concentration of about one eighth of one percent by volume.
HENRYC. MILLER.
REFERENCES CITED The following references are of record in the file of this patent:
OTHER REFERENCES

Claims (1)

1. A READILY REDISPERSIBLE SUBSTANTIALLY WATERFREE THERAPEUTIC COMPOSITION COMPRISING A MAJOR PROPORTION OF AN OLEAGINOUS VEHICLE, A MINOR PROPORTION OF A FINELY DIVIDED WATER-INSOLUBLE, AND OIL-INSOLUBLE ORGANIC PENICILIN SALT AND AN AMOUNT EFFECTIVE TO CAUSE REDISPERSION AND LESS THAN ABOUT ONE PERCENT BY VOLUME OF AT LEAST ONE EMULSIFYING AGENT OF THE GROUP CONSISTING OF THE FATTY ACID PARTIAL ESTERS OF HEXITIL ANHYDRIDES AND THEIR POLYALKYLENE OXIDE DERIVATIVES.
US1277A 1948-01-08 1948-01-08 Penicillin salt suspensions Expired - Lifetime US2544272A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US1277A US2544272A (en) 1948-01-08 1948-01-08 Penicillin salt suspensions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1277A US2544272A (en) 1948-01-08 1948-01-08 Penicillin salt suspensions

Publications (1)

Publication Number Publication Date
US2544272A true US2544272A (en) 1951-03-06

Family

ID=21695221

Family Applications (1)

Application Number Title Priority Date Filing Date
US1277A Expired - Lifetime US2544272A (en) 1948-01-08 1948-01-08 Penicillin salt suspensions

Country Status (1)

Country Link
US (1) US2544272A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
US2725336A (en) * 1950-11-06 1955-11-29 Pfizer & Co C Preparation containing modified procaine penicillin crystals and process for preparing such crystals
US2812283A (en) * 1950-11-29 1957-11-05 Geschickter Fund Med Res Therapeutic solvent vehicle
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2928769A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of controlled release medicaments
US3049473A (en) * 1956-08-13 1962-08-14 Ici Ltd Udder-dispersible antibiotic mastitis creams
US3194733A (en) * 1961-04-26 1965-07-13 Olin Mathicson Chemical Corp Phenothiazine compositions and method of treating mental disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2725336A (en) * 1950-11-06 1955-11-29 Pfizer & Co C Preparation containing modified procaine penicillin crystals and process for preparing such crystals
US2812283A (en) * 1950-11-29 1957-11-05 Geschickter Fund Med Res Therapeutic solvent vehicle
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
US3049473A (en) * 1956-08-13 1962-08-14 Ici Ltd Udder-dispersible antibiotic mastitis creams
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2928769A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of controlled release medicaments
US3194733A (en) * 1961-04-26 1965-07-13 Olin Mathicson Chemical Corp Phenothiazine compositions and method of treating mental disorders

Similar Documents

Publication Publication Date Title
US2507193A (en) Penicillin product
DE3856297T2 (en) Amorphous form of aztreonam
DE69728783T2 (en) IMPROVED MEDICINES
JPH06507913A (en) Novel compositions based on derivatives of taxanes
US2544272A (en) Penicillin salt suspensions
EP0233849B1 (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
DE2635476C2 (en) Veterinary medicinal products
US4087538A (en) Ophthalmic suspensions
JPS647046B2 (en)
US2768112A (en) Repository vitamin compositions
JPH0558410B2 (en)
DE2611183A1 (en) STABLE DOSAGE FORM OF PROSTAGLANDIN-LIKE COMPOUNDS
DE2310770A1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING PENICILLIN COMPOUNDS
US2518510A (en) Stable injectable oil-pectin therapeutic compositions
CA1160571A (en) Antitumor compositions
US2966442A (en) Antibiotic compositions
US2600344A (en) Androgenic composition
IE42951B1 (en) Injectable antibiotic compositions
US2725336A (en) Preparation containing modified procaine penicillin crystals and process for preparing such crystals
WO1989005638A1 (en) Emulsion for parenteral administration
US2656299A (en) Penicillin compositions
US2650217A (en) Production of quinine-penicillin
US3170836A (en) Injectable compositions comprising a copper-containing chelate complex compound dispersed in a stabilized oil-in-water emulsion and method of using the same
US2719103A (en) D-tubo-curarine chloride in suspension of water-insoluble soap in injectable oil
US2694665A (en) Procaine-penicillin g composition